Legionella pneumophila is responsible for hospital or community-acquired pneumonia. Neonatal legionellosis is associated with rapidly severe clinical course and high mortality rates. We describe a case of hospital-acquired Legionella pneumonia in a newborn with undiagnosed tracheoesophageal fistula and acute respiratory failure requiring venovenous extracorporeal membrane oxygenation support before fistula repair. Standardized multiplex polymerase chain reaction assay allowed early diagnosis. Extracorporeal life support associated with appropriate antibiotic therapy, surfactant, and steroid therapy was effective in achieving complete recovery. This is the first report of successful neonatal extracorporeal life support for respiratory failure secondary to L pneumophila.
Since the first known outbreak of Legionnaires' disease in 1976, a significant increase of Legionella infections have been documented in recent years, likely due to increased awareness and recognition of the pathogen with rapid diagnostic test availability. 1 Drs Moscatelli and Buratti designed the case report, drafted the initial manuscript, and revised the manuscript; Dr Castagnola coordinated, critically revised, and reviewed the manuscript; Dr Mesini carried out the initial analysis of the case, reviewed the literature, and revised the manuscript; Dr Tuo coordinated and conceptualized the initial manuscript and critically reviewed and revised the manuscript; and all the authors approved the final manuscript as submitted.
www.pediatrics.org/cgi/doi/10.1542/peds. in the posterior wall of the trachea, 1.5 cm from the carina (H-type).
In the following days, she presented progressive worsening of the bilateral pulmonary infiltrates, high ventilatory parameters, increasing C-reactive protein (maximum 20 mg/dL), urticariod rash, and signs of septic shock. High-frequency oscillatory ventilation and inhaled nitric oxide were not effective (oxygenation index 65); hemodynamic support with epinephrine was started. On DOL 16, VV-ECMO was commenced with resting settings on high-frequency oscillatory ventilation. Ultrafiltration was required for oligoanuria and severe fluid overload. Hemodynamic status improved on VV-ECMO. On ECMO day 1, screening for viral and bacterial respiratory pathogens became available and was positive for Legionella pneumophila, confirmed on 2 samples of bronchoalveolar lavage by real-time PCR. Serogroup was not analyzed. Antibiotic therapy with ampicillin, rifampin, and azithromycin was administered for 21 days. Methylprednisolone pulses, surfactant administration with flexible bronchoscopy, surfactant lavages, and respiratory physiotherapy were implemented. Improvement of pulmonary infiltrates was observed in the following days. After 10 days, ECMO support was discontinued (DOL 26), and the patient was stable on conventional ventilation. Chest computed tomography on DOL 30 demonstrated diffuse ground glass infiltrates and consolidations with bilateral cystic lesions of various sizes, the main one in the right inferior lobe, 20 3 30 3 20 mm in size (Fig 1) . Surgical repair of TEF by right cervical approach was performed 5 weeks after ECMO discontinuation to allow adequate resolution of the cervical hematoma due to surgical cannulation and repair of the internal jugular vein. Postoperative course was complicated by bilateral vocal cord paralysis requiring tracheostomy at 4 months of age. At 1 year of age, chest compute tomography showed resolution of the cystic lesions with mild ground glass appearance in the right inferior lobe and bilateral linear fibrotic lesions in the posterior aspects of the lower lobes (Fig 1) . Follow-up has been uneventful, and the patient is asymptomatic with normal neurodevelopmental outcome at 2 years of life. Environmental cultures performed in the birth center after the diagnosis of Legionella infection in our patient demonstrated colonization of the water distribution system with Legionella pneumophila. No other cases were identified.
DISCUSSION
Legionella pneumophila is a Gramnegative bacillus responsible for hospital or community-acquired pneumonia. Legionella is considered a rare cause of pneumonia in immunocompetent children, and in a review of 76 pediatric cases, 38% were under 1 year of age. 5 The incubation period ranges between 2 and 7 days. 9 Legionella is acquired through inhalation of contaminated aerosolized water from cooling towers, humidifiers, respiratory therapy equipment, and potable water systems. As in our case, a positive environmental link has been identified in 88% of pediatric cases of hospital-acquired Legionella. 5 A large outbreak of Legionella infection in term neonates in Cyprus occurred in 2008 due to contamination of a cold mist humidifier. 4 Hospital and domestic birthing pools have also been reported as source of severe or fatal infections in the neonatal period. 3, 5, 10 Clinical presentation, radiologic features and natural course of Legionella pneumonia in children are not specific and often similar to other forms of pneumonia. 5 Clinical presentation may range from mild symptoms to a fulminating course complicated by multiple organ failure. Immunosuppression, neoplasms, immunodeficiency, organ transplantation, and underlying pulmonary disease are recognized risk factors in the adult and pediatric population, where neonatal age and prematurity are additional risk factors for severe disease. 1, 5 Mortality rates of severe Legionella pneumonia are high, 30% to 33% in adult ICUs, 11,12 23% to 41% in the pediatric age, and 55% in neonatal cases. 5 Urine antigen testing, culture from respiratory tract secretions or pleural fluid, and antibody titers could be used for diagnosis, although DNA amplification by PCR warrants high specificity and rapid response if standardized assays are available. 13 Intravenous azithromycin is the current treatment of choice for L pneumophila in the pediatric patients. 1, 14 Combination therapy with rifampin is recommended in severe cases, although no evident additional benefits have been demonstrated. 1, 15 It has been noted that mortality rates are significantly lower in children treated with timely and appropriate antibiotic therapy (23% vs 70%). 5 Empirical therapies for community-acquired pneumonia or neonatal sepsis are not efficacious in Legionella infection. In cases in which pneumonia is not responsive to b lactamase therapy, Legionella should be suspected and specific diagnostic tests should performed.
FIGURE 1
Nonenhanced chest computed tomography scan. A, After discontinuation of VV-ECMO. B, At 1 year of age showing complete resolution of consolidations and cystic lesions; residual ground-glass appearance and fibrosis.
Lung injury and severe respiratory failure in the reported case were likely secondary to 2 coincident factors: Legionella infection and inhalation due to undiagnosed TEF. ECLS is an effective treatment of acute respiratory failure due to several etiologies when conventional ventilatory support fails. Series and single cases of ECLS for severe Legionella pneumonia in adult patients have been reported, 6-8 but, to our knowledge, only 1 case of ECMO support for neonatal Legionella infection is reported in the literature with no mention of outcome. 16 Query of the Extracorporeal Life Support Organization registry (1990-2014) identified 2 neonatal cases (9 and 17 days of life) and 2 infants with Legionella pneumonia supported with venovenous or venoarterial ECMO with no survivors. In the most recent retrospective study of 12 adult patients with Legionella pneumonia treated with VV-ECMO, 75% of patients were successfully weaned off ECLS, with 67% survival to discharge, 6 compared with 25% survival in a previous study of 8 confirmed cases. 7 Our patient was successfully weaned off ECLS after a 10 day-course of VV-ECMO without significant complications.
The role of surfactant replacement therapy in ARDS is controversial. Experimental and clinical evidence demonstrated surfactant dysfunction with quantitative and qualitative abnormalities of both phospholipids and proteins. 17 It has been proven that Legionella species secrete phospholipase A, which may act as a powerful agent in the mediation of pathogenicity due to destruction of lung surfactant and epithelial cells. 18 Exogenous surfactant therapy during ECMO and surfactant lavage to remove thick respiratory secretions seemed to be an effective therapeutic strategy. Recent reviews and metaanalysis suggest that the use of lowdose corticosteroids is associated with improved mortality and morbidity outcomes and that they may play an effective role as adjunctive therapy for ARDS in adults. 19 Low-dose methylprednisolone in our patient was not associated with adverse effects. 
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